Since lipopolysaccharide (LPS)-induced exacerbation of experimental asthma in mice is also associated with increased release of IL-17A and can be blocked by an antibody directed against this cytokine, IL-17A could indeed play a significant role during acute asthma exacerbations triggered by bacteria as well as respiratory viruses [77]. The gene discussed is IL17A; the disease is asthma.